Treatment is aimed at opening the blocked veins to minimize complications; the duration of clot (acute versus chronic) affects treatment. Unless there are underlying reasons why it would be harmful, anticoagulation (low molecular weight heparin, followed by warfarin) is often initiated and maintained in patients who do not have cirrhosis. Anticoagulation for patients with cirrhosis who experience<unk>  is usually not advised unless they have chronic<unk>  1) with thrombophilia, 2) with clot burden in the mesenteric veins, or 3) inadequate blood supply to the bowels. In more severe instances, shunts or a liver transplant may be considered. If blood flow to the gastrointestinal tract has been compromised chronically, surgery may be required to remove dead intestine. Different considerations are made in the management of<unk>  in pediatric patients or those who have already received a liver transplant.
Portal vein thrombosis
Phlebothrombosis
Hepatic artery thrombosis
Deep vein thrombosis
Septic thrombophlebitis
Varicose veins
Pseudothrombophlebitis
Superficial vein thrombosis